Johnson Investment Counsel Inc Astrazeneca PLC Transaction History

Johnson Investment Counsel Inc

$10.2 Billion
Q1 2025

A detailed history of Johnson Investment Counsel Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 9,907 shares of AZN stock, worth $692,697. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,907

Previous 9,493 4.36%

Holding current value

$692,697

Previous $621,000 17.23%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	BUY	$65.37 - $77.96 $27,063 - $32,275	414 Added 4.36%	9,907 $728,000
Q4 2024 Feb 07, 2025	BUY	$63.2 - $79.58 $178,982 - $225,370	2,832 Added 42.52%	9,493 $621,000
Q3 2024 Nov 04, 2024	SELL	$76.67 - $87.62 $37,031 - $42,320	-483 Reduced 6.76%	6,661 $519,000
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $47,368 - $57,308	709 Added 11.02%	7,144 $557,000
Q1 2024 May 09, 2024	SELL	$61.03 - $69.57 $2,929 - $3,339	-48 Reduced 0.74%	6,435 $435,000
Q4 2023 Feb 07, 2024	BUY	$61.89 - $69.28 $49,388 - $55,285	798 Added 14.04%	6,483 $436,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $43,319 - $47,895	668 Added 13.31%	5,685 $384,000
Q2 2023 Aug 10, 2023	BUY	$69.91 - $75.81 $18,526 - $20,089	265 Added 5.58%	5,017 $359,000
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $18,439 - $20,907	-292 Reduced 5.79%	4,752 $329,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $2,818 - $3,662	52 Added 1.04%	5,044 $341,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $3,075 - $7,873	-58 Reduced 1.15%	4,992 $274,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $16,948 - $20,346	-286 Reduced 5.36%	5,050 $334,000
Q1 2022 May 11, 2022	SELL	$55.72 - $67.12 $53,212 - $64,099	-955 Reduced 15.18%	5,336 $354,000
Q4 2021 Feb 15, 2022	SELL	$54.02 - $63.83 $53,695 - $63,447	-994 Reduced 13.64%	6,291 $366,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $67,060 - $73,373	1,207 Added 19.86%	7,285 $438,000
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $32,538 - $40,440	-672 Reduced 9.96%	6,078 $364,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $76,304 - $88,083	-1,618 Reduced 19.34%	6,750 $336,000
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $66,957 - $80,067	1,380 Added 19.75%	8,368 $418,000
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $4,882 - $5,621	92 Added 1.33%	6,988 $383,000
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $49,996 - $64,159	-1,160 Reduced 14.4%	6,896 $365,000
Q1 2020 May 20, 2020	BUY	$37.79 - $51.33 $9,712 - $13,191	257 Added 3.3%	8,056 $360,000
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $28,023 - $33,303	660 Added 9.24%	7,799 $389,000
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $286,416 - $324,610	7,139 New	7,139 $318,000

Others Institutions Holding AZN

# of Institutions

1,426

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $217B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Astrazeneca PLC Transaction History